Skip to main content

Published locations for FDA approves trastuzumab-anns for HER2-positive breast, gastric cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves trastuzumab-anns for HER2-positive breast, gastric cancer

User login

  • Reset your password
  • /content/fda-approves-trastuzumab-anns-her2-positive-breast-gastric-cancer
  • /fedprac/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast-gastric
  • /obgynnews/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast-gastric
  • /oncologypractice/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast
  • /fedprac/avaho/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast
  • /jcomjournal/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast-gastric
  • /obgyn/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast-gastric-cancer
  • /hematology-oncology/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast
  • /breast-cancer-icymi/article/202923/breast-cancer/fda-approves-trastuzumab-anns-her2-positive-breast